Combatting Antimicrobial Resistance: Public Health Policies, Community Awareness and Global Surveillance
Nabil Deb Nath1*, Asim Debnath1, Md Abu Bakar Siddique1, Tufael2
Clinical Epidemiology & Public Health 2(1) 1-8 https://doi.org/10.25163/health.2110280
Submitted: 01 April 2024 Revised: 09 June 2024 Published: 12 June 2024
Abstract
Antimicrobial resistance (AMR) poses a growing threat to global health, complicating the treatment of infections and increasing healthcare costs worldwide. Combating antimicrobial resistance (AMR) requires a comprehensive approach that involves strong public health policies, effective governance, adequate funding, and robust surveillance systems to monitor resistance trends. Equally important is community engagement, which raises awareness and promotes the responsible use of antibiotics tailored to diverse cultural and social contexts. When communities feel a sense of belonging and are actively involved, they become empowered to make informed decisions, which helps curb the misuse of antimicrobials. Despite significant progress, many low- and middle-income countries face challenges, including limited political commitment, resource constraints, and weak regulatory frameworks, which hinder the effective implementation of national action plans. Strengthening healthcare infrastructure, enhancing laboratory capacity, and promoting collaboration among governments, civil society, and international partners are crucial steps forward. Future strategies should prioritize refining communication efforts to better resonate with local populations and ensure that educational campaigns result in lasting behavioral changes. The upcoming High-Level Meeting on AMR presents a critical opportunity for nations to commit to more decisive, more inclusive actions. By working together across sectors and borders, we can address the complex challenge of antimicrobial resistance (AMR) and protect the effectiveness of life-saving medicines for generations to come.
Keywords: Antimicrobial Resistance (AMR), Community Engagement, Public Health Policy, Surveillance Systems, Antibiotic Stewardship.
References
Allouch, A., Sabbah, H., Hassan, S., & et al. (2016). Antibiotic use, cost, and consumption in tertiary hospitals in Lebanon: A comparative study before and after implementation of an antibiotic-restriction program (ARP). British Journal of Medicine and Medical Research, 12, 1–15.
Anubhav Dubey, Mamta Kumari (2024). Antimicrobial activity, Phytochemical Screening of Crude Extracts, and Essential Constituents of Syzygium Aromaticum, Tymus Vulgaris and Eucalyptus Globulus on Selected Pathogens, Microbial Bioactives, 7(1), 1–5, 9791
Altunsoy, A., Aypak, C., Azap, A., & et al. (2011). The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. International Journal of Medical Sciences, 8, 339–344.
Belongia, E. A., Knobloch, M. J., Kieke, B. A., & et al. (2005). Impact of statewide program to promote appropriate antimicrobial use. Emerging Infectious Diseases, 11, 912–920.
Bernier, A., Elisabeth, D. A., Ligier, C., & et al. (2014). Outpatient Antibiotic Use in France: Post-Campaign Focus on the Elderly. Antimicrobial Agents and Chemotherapy, 58, 71–77.
Chahwakilian, P., Huttner, B., Schlemmer, B., & et al. (2011). Impact of the French campaign to reduce inappropriate ambulatory antibiotic use. Journal of Antimicrobial Chemotherapy, 66, 2872–2879.
Cheng, A. C., Turnidge, J., Collignon, P., & et al. (2012). Control of fluoroquinolone resistance through regulation: Emerging Infectious Diseases, 18, 1453.
Chou, Y., Yip, W. C., Lee, C. H., et al. (2003). Impact of separating drug prescribing and dispensing: Taiwan’s experience. Health Policy and Planning, 18, 316–329.
Duborija-Kovacevic, N. (2006). Antibiotic prescribing policy in Montenegro: Effects of drug utilization reform. Medicinski Pregled, 59, 235–240.
Fürst, J., Cižman, M., Mrak, J., & et al. (2015). The Influence of a Sustained, Multifaceted Approach to Improve Antibiotic Prescribing in Slovenia. Expert Review of Anti-Infective Therapy, 13, 279–289.
Goosens, H., Coenen, S., Costers, M., & et al. (2008). Achievements of the Belgian antibiotic policy coordination committee (BAPCOC). Euro Surveillance, 13, pii=19036.
Hindi, A. A., AL-isawi, Z. S. O., Baker, S. S. M. (2024). "Antioxidant Enzyme Deficiency and Oxidative Stress in Asthma: Implications for Therapeutic Antioxidant Strategies", Microbial Bioactives, 7(1),1-6,10104
Hemo, B., Shamir-Shtein, N. H., Silverman, B. G., & et al. (2009). Can a nationwide media campaign affect antibiotic use? American Journal of Managed Care, 15, 529–534.
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., & et al. (2018). Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proceedings of the National Academy of Sciences of the USA, 115, E3463–E3470.
Kliemann, B. S., Levin, A. S., Moura, M. L., & et al. (2016). Socioeconomic Determinants of Antibiotic Consumption in São Paulo. PLoS One, 11, e0167885.
Kim, B. N., Kim, B. H., & Oh, M. D. (2016). Antibiotic control policies in South Korea, 2000–2013. Infection & Chemotherapy, 48, 151–159.
Lambert, M. F., Masters, G. A., & Brent, S. L. (2007). Can mass media campaigns change antimicrobial prescribing? Journal of Antimicrobial Chemotherapy, 59, 537–543.
Liou, J. M., Chang, C. Y., Chen, M. J., et al. (2015). Primary Resistance of Helicobacter pylori in Taiwan Following the Implementation of a National Antibiotic Policy. PLoS One, 10, e0124199.
Lim, J. M., Singh, S. R., Duong, M. C., Legido-Quigley, H., Hsu, L. Y., & Tam, C. C. (2020). Impact of national interventions to promote responsible antibiotic use: a systematic review. The Journal of Antimicrobial Chemotherapy, 75(1), 14–29. https://doi.org/10.1093/jac/dkz348
Malmvall, B. E., Mölstad, S., Darelid, J., & et al. (2007). Reduction of antibiotics sales and low bacterial resistance: Evidence from Jönköping County, Sweden. Quality Management in Health Care, 16, 60–67.
Marshall, D., Gough, J., Grootendorst, P., et al. (2006). Impact of administrative restrictions on antibiotic use in Ontario. Journal of Health Services Research & Policy, 11, 13–20.
Md. Tahsin Salam, Kaniz Fatema Bari et al. (2024). Emergence of Antibiotic-Resistant Infections in ICU Patients, Journal of Angiotherapy, 8(5), 1-9, 9560
Mona A. Hussein, Salem, H.A. (2024). Biocontrol of Chocolate Banded Snail Using Steinernema Nematodes in Egypt, Microbial Bioactives, 7(1), 1–6, 9666
Moher, D., Liberati, A., Tetzlaff, J., & et al. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6, e1000097.
Mölstad, S., Erntell, M., Hanberger, H., & et al. (2008). Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infectious Diseases, 8, 125–132.
Nathwani, D., Sneddon, J., Malcolm, W., et al. (2011). Scottish Antimicrobial Prescribing Group (SAPG): Development and impact of the Scottish National Antimicrobial Stewardship Programme. International Journal of Antimicrobial Agents, 38, 16–26.
Parsons, S., Morrow, S., & Underwood, M. (2004). Did local campaign enhancements reduce antibiotic prescribing? European Journal of General Practice, 10, 18–23.
Patrick, D. M., Marra, F., Hutchinson, J., et al. (2004). Per Capita Antibiotic Consumption: North America vs. Europe Clinical Infectious Diseases, 39, 11–17.
Plachouras, D., Antoniadou, A., Giannitsioti, E., & et al. (2014). Promoting prudent use of antibiotics: A regional campaign in Greece. BMC Public Health, 14, 866.
Rahman, M. H., Aunni, S. A. A., Ahmed, B., Rahman, M. M., Shabuj, M. M. H., Das, D. C., Akter, M. S., Numan, A. A. (2024). "Artificial intelligence for Improved Diagnosis and Treatment of Bacterial Infections", Microbial Bioactives, 7(1),1-18,10036
Review on Antimicrobial Resistance. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Retrieved from https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
Rivas, P., & Alonso, G. (2011). Impact of drug dispensing regulations on antibiotic use in Venezuela. Revista Panamericana de Salud Pública, 30, 592–597.
Sabuncu, E., David, J., Bernède-Bauduin, C., & et al. (2009). Reduction of community antibiotic use following a French nationwide campaign, 2002–2007. PLoS Medicine, 6, 1–9.
Shamsuddin Sultan Khan, John Anthony Catanzaro. (2023). Individualized Therapeutic Design against Lyme disease, Microbial Bioactives, 6(1), 1-8, 9391.
World Health Organization. (2015). Global action plan on antimicrobial resistance. Retrieved from https://www.who.int/antimicrobial-resistance/global-action-plan/en/
View Dimensions
View Altmetric
Save
Citation
View
Share